Cover Image
市場調查報告書

蛋白質體學的全球市場:2015年∼2019年

Global Proteomics Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 269614
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
蛋白質體學的全球市場:2015年∼2019年 Global Proteomics Market 2015-2019
出版日期: 2015年04月22日 內容資訊: 英文 80 Pages
簡介

全球蛋白質體學市場,預計從2014年到2019年,以8.39%的年複合成長率擴大。這個成長的要素之一,為對個人化醫療的需求增加。

本報告提供全球蛋白質體學市場概要和市場規模和未來預測、藥價與償付、主要的設備趨勢、市場成長因素與課題、主要供應商的資訊等。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 概要

  • 研究所蛋白質體學技術
  • 醫療保健蛋白質體學
    • 腫瘤蛋白質體學
    • 神經蛋白質體學
  • 醫療的蛋白質體學的生物標記
  • 蛋白質體學的工作流程的技術

第7章 藥價及償付方案

  • 藥價
  • 償付
    • 美國的分子診斷的償付結構
    • 歐洲的分子診斷的償付結構

第8章 蛋白質體學的主要設備

  • 質譜分析設備
  • 二元電泳設備
  • 蛋白質生物晶片

第9章 國際蛋白質體學團體

  • Initiatives sponsored by Human Proteomics Organization

第10章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第11章 人血漿蛋白質的分類

第12章 各分類的市場分類

  • 質譜分析設備
  • 二元電泳設備
  • 蛋白質生物晶片

第13章 地理區分

  • 南北美洲
    • 市場規模與預測
  • 歐洲、中東、非洲地區
    • 市場規模與預測
  • 亞太地區
    • 市場規模與預測

第14章 購買標準

第15章 市場成長因素

第16章 成長因素與其影響

第17章 市場課題

第18章 成長因素與課題的影響

第19章 市場趨勢

第20章 趨勢與其影響

第21章 業者情勢

  • 競爭模式
    • 主要消息
    • M&A
  • 市場佔有率分析
  • 其他卓越供應商

第22章 主要供應商分析

  • Agilent Technologies
  • Danaher
  • Thermo Fisher

第23章 相關報告

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR5701

About Proteomics

Proteomics is a systematic study of proteins on a large scale, particularly their functions and structures. Proteomics has the potential to answer some key questions that were unsolved by genomics, because proteins are the functional unit of cells. Proteomics research is enhanced by both protein and DNA sequence databases, advances in mass spectrometry, and development of computer algorithms for database searching. The most common application of proteomics is the analysis of target proteins. Proteomics requires various instruments, consumables, reagents, media, and software for protein identification, purification, quantification, and investigation of the interaction between various proteins. Proteins can undergo post-translational modifications to form three-dimensional structures, which can easily be identified by proteomics.

TechNavio's analysts forecast the Global Proteomics market to grow at a CAGR of 8.39 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Proteomics market for the period 2015-2019. The market can be divided into two segments: Equipment and Consumables.

TechNavio's report, the Global Proteomics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the Global Proteomics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Agilent Technologies
  • Danaher
  • Thermo Fischer Scientific

Other Prominent Vendors

  • AB Sciex
  • Abbott Laboratories
  • Affymetrix
  • AMS Biotechnology
  • Avacta Life Sciences
  • BD Biosciences
  • Biocompare
  • Bio-Rad
  • Bio-WORLD
  • Bruker Daltonics
  • Caprion Proteomics
  • Cellzome AG
  • Dionex
  • GE Healthcare Life Sciences
  • Flowgen Bioscience
  • Fluidigm
  • Illumina
  • MRM Proteomics
  • Ocular Proteomics
  • Perkin Elmer
  • Pragati Biomedical
  • Proteomics International
  • Proteomics Sciences
  • Roche Diagnostics
  • Sera Proteomics
  • Shimadzu
  • SGS
  • Sigma-Aldrich
  • Waters
  • Xencor

Market Driver

  • Increase in Demand for Personalized Medicines
  • For a full, detailed list, view our report

Market Challenge

  • Ethical, Privacy, and Practical Issues
  • For a full, detailed list, view our report

Market Trend

  • Shift from Genomics to Proteomics
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market overview
  • 03.2. Product offerings

04. Market Research Methodology

  • 04.1. Market research process
  • 04.2. Research methodology

05. Introduction

06. Overview

  • 06.1. Laboratory applications of proteomic technologies
  • 06.2. Healthcare applications of proteomics
    • 06.2.1. Oncoproteomics
    • 06.2.2. Neuroproteomics
  • 06.3. Medicinal applications of proteomics-based biomarkers
  • 06.4. Technologies for proteomics workflow

07. Pricing and Reimbursement Scenario

  • 07.1. Pricing
  • 07.2. Reimbursement
    • 07.2.1. The US molecular diagnostics reimbursement structure
    • 07.2.2. The European molecular diagnostics reimbursement structure

08. Leading Equipment for Proteomics

  • 08.1. Mass spectrometry
  • 08.2. 2-D electrophoresis
  • 08.3. Protein biochips

09. International Proteomics Associations

  • 09.1. Initiatives sponsored by Human Proteomics Organization

10. Market Landscape

  • 10.1. Market overview
  • 10.2. Market size and forecast
  • 10.3. Five forces analysis

11. Global Categorization of Detected Human Plasma Proteins

12. Market Segmentation by Category

  • 12.1. Proteomics market for mass spectrometry
  • 12.2. Proteomics market for 2-D electrophoresis
  • 12.3. Proteomics market for protein biochips
  • 12.4. Proteomics market for consumables

13. Geographical Segmentation

  • 13.1. Proteomics market in Americas
    • 13.1.1. Market size and forecast
  • 13.2. Proteomics market in EMEA
    • 13.2.1. Market size and forecast
  • 13.3. Proteomics market in APAC
    • 13.3.1. Market size and forecast

14. Buying Criteria

15. Market Growth Drivers

16. Drivers and their Impact

17. Market Challenges

18. Impact of Drivers and Challenges

19. Market Trends

20. Trends and their Impact

21. Vendor Landscape

  • 21.1. Competitive scenario
    • 21.1.1. Key News
    • 21.1.2. Mergers and Acquisitions
  • 21.2. Market share analysis 2014
  • 21.3. Other prominent vendors

22. Key Vendor Analysis

  • 22.1. Agilent Technologies
    • 22.1.1. Key facts
    • 22.1.2. Business overview
    • 22.1.3. Business segmentation by revenue 2013
    • 22.1.4. Business segmentation by revenue 2012 and 2013
    • 22.1.5. Geographical segmentation by revenue 2013
    • 22.1.6. Business strategy
    • 22.1.7. Recent developments
    • 22.1.8. SWOT analysis
  • 22.2. Danaher
    • 22.2.1. Key facts
    • 22.2.2. Business overview
    • 22.2.3. Business segmentation
    • 22.2.4. Revenue by business segmentation
    • 22.2.5. Revenue comparison 2012 and 2013
    • 22.2.6. Segmentation by geography
    • 22.2.7. Business strategy
    • 22.2.8. Key information
    • 22.2.9. SWOT analysis
  • 22.3. Thermo Fisher
    • 22.3.1. Key facts
    • 22.3.2. Business overview
    • 22.3.3. Business segmentation
    • 22.3.4. Business segmentation by revenue
    • 22.3.5. Product segmentation by revenue
    • 22.3.6. Geographical segmentation by revenue 2013
    • 22.3.7. Business strategy
    • 22.3.8. Key information
    • 22.3.9. SWOT analysis

23. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market research methodology
  • Exhibit 2: Proteomics workflow overview
  • Exhibit 3: Proteomics technologies by laboratory applications
  • Exhibit 4: Proteomics technologies by healthcare applications
  • Exhibit 5: Proteomic-based biomarkers in various aspects of medicine
  • Exhibit 6: Technologies applied at various stages of proteomics process
  • Exhibit 7: Molecular diagnostic devices pricing influencers
  • Exhibit 8: Medicare perspective of diagnostic reimbursement
  • Exhibit 9: International associations dedicated to proteomics
  • Exhibit 10: Initiatives sponsored by Human Proteomics Organization
  • Exhibit 11: Key takeaways
  • Exhibit 12: Global proteomics market 2014-2019 ($ million)
  • Exhibit 13: Process workflow for characterization of human plasma proteome
  • Exhibit 14: Categorization of detected human plasma proteins (%)
  • Exhibit 15: Categorization of detected cellular proteins (%)
  • Exhibit 16: Categorization of detected classic plasma proteins (%)
  • Exhibit 17: Categorization of detected cytokine and related proteins (%)
  • Exhibit 18: Proteomics market for mass spectrometry 2014-2019 ($ million)
  • Exhibit 19: Proteomics market for 2-D electrophoresis 2014-2019 ($ million)
  • Exhibit 20: Proteomics market for protein biochips 2014-2019 ($ million)
  • Exhibit 21: Proteomics market for consumables 2014-2019 ($ million)
  • Exhibit 22: Segmentation of global proteomics market by geography 2014
  • Exhibit 23: Segmentation of global proteomics market by geography 2019
  • Exhibit 24: Segmentation of global proteomics market by geography 2014-2019
  • Exhibit 25: Proteomics market in Americas 2014-2019 ($ million)
  • Exhibit 26: Proteomics market in EMEA 2014-2019 ($ million)
  • Exhibit 27: Proteomics market in APAC 2014-2019 ($ million)
  • Exhibit 28: Agilent Technologies: business segmentation by revenue 2013
  • Exhibit 29: Agilent Technologies: business segmentation by revenue 2012 and 2013 ($ billion)
  • Exhibit 30: Agilent Technologies: geographical segmentation by revenue 2013
  • Exhibit 31: Danaher: Business Segmentation
  • Exhibit 32: Danaher: business segmentation 2013
  • Exhibit 33: Danaher: revenue by business segmentation 2012 and 2013 ($ million)
  • Exhibit 34: Danaher: revenue by geographical segmentation 2013
  • Exhibit 35: Thermo Fisher: business segmentation
  • Exhibit 36: Thermo Fisher: business segmentation by revenue 2013
  • Exhibit 37: Thermo Fisher: product segmentation by revenue 2013
  • Exhibit 38: Thermo Fisher: geographical segmentation by revenue 2013
Back to Top